Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome

Published 2019 View Full Article

Authors

Keywords

Polycystic ovary syndrome, Hypercholesterolemia, Ovarian function, Proprotein convertase subtilisin/kexin type-9, Low-density lipoprotein receptor, Alirocumab

Journal

METABOLISM-CLINICAL AND EXPERIMENTAL

Volume 94, Issue -, Pages 47-58

Publisher

Elsevier BV

Online

2019-02-13

DOI

10.1016/j.metabol.2019.02.002

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started